Skip to content Skip to footer
Subscribe Now
NEWS

IntraGel Therapeutics and UroGen Pharma Ink Strategic Collaboration &  Investment to Advance TumoCure & Expand Sustained-Release Oncology Pipeline

Shots: IntraGel Therapeutics has entered into a strategic collaboration and investment agreement with UroGen Pharma to advance TumoCure for advanced head and neck cancer and expand the potential application of its SRGel biodegradable sustained-release platform As per the deal, UroGen will invest up to $7M in IntraGel to support the P-II development of TumoCure and…
August 21, 2026

Read more

CXO TALKS

CXO Talks Podcast | Building Smarter Biotech: Venkat Nelabhotla, CEO of Vyome Holdings, on Driving Innovation Across the US–India Corridor

Shots: In a thought-provoking conversation with PharmaShots CXO Talks, Venkat Nelabhotla, Co-Founder, President & CEO of Vyome Holdings, discussed how disciplined execution, strategic capital allocation, and focused innovation are shaping the company's approach to developing therapies for high unmet medical needs while strengthening the US–India biotech innovation corridor. Venkat highlighted Vyome's strategy of leveraging drug…
July 22, 2026

Read more

Know Your Investor: Alexandria Venture (May’25 Edition)
INSIGHTS+

Know Your Investor: Alexandria Venture (May’25 Edition)

Shots:     Welcome to the 2025 edition of Know Your Investor, spotlighting leading venture capital firms driving innovation in healthcare.  This edition features Alexandria Venture Investments, a firm committed to supporting disruptive life science companies that aim to improve human health.  In 2024, the firm invested approximately $2.7B across six public and private funding rounds, adding…
May 15, 2025

Read more